The JI
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     
 


This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Kundig, T. M.
Right arrow Articles by Zinkernagel, R. M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Kundig, T. M.
Right arrow Articles by Zinkernagel, R. M.

The Journal of Immunology, Vol 150, Issue 10 4450-4456, Copyright © 1993 by American Association of Immunologists


ARTICLES

Nonimmunogenic tumor cells may efficiently restimulate tumor antigen- specific cytotoxic T cells

TM Kundig, MF Bachmann, L Lefrancois, L Puddington, H Hengartner and RM Zinkernagel
Institute of Experimental Immunology, University of Zurich, Switzerland.

Induction of immunity to a viral protein that had been transfected into a tumor cell line was studied. The nucleoprotein (NP) of vesicular stomatitis virus (VSV) was used as a model tumor-associated Ag after transfection into EL-4, and H-2b thymoma originating from C57BL/6 mice. The NP-transfected cell line (EL-4NP) was lysed by NP-specific CTL and was found to restimulate NP-specific CTL in vitro as efficiently as did VSV-infected macrophages. Despite both of these in vitro characteristics, C57BL/6 mice inoculated with EL-4NP did not mount a measurable NP-specific CTL response and developed a lethal tumor as rapidly as did mice given control EL-4. This lack of immunogenicity could not be explained by down-regulation of MHC class I molecules or by loss of NP; even EL-4NP cells metastasizing to the spleen kept their high restimulatory capacity and excellent target characteristics. However, once mice were immunized with VSV or with a vaccinia-VSV-NP recombinant virus they were protected against tumor growth of EL-4NP by CD8+ CTL but not by CD4+ T cells. Taken together, the failure of the tumor-associated Ag to induce a protective T cell response in vivo despite its excellent capacity to restimulate CTL in vitro may encourage adjuvant immunotherapy in cancer; even the effects of weakly immunizing tumor vaccines, e.g., recombinant viruses, may be efficiently amplified by tumor cells.


This article has been cited by other articles:


Home page
Proc. Natl. Acad. Sci. USAHome page
P. Johansen, T. Storni, L. Rettig, Z. Qiu, A. Der-Sarkissian, K. A. Smith, V. Manolova, K. S. Lang, G. Senti, B. Mullhaupt, et al.
Antigen kinetics determines immune reactivity
PNAS, April 1, 2008; 105(13): 5189 - 5194.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
I. Erdmann, E. P. Scheidegger, F. K. Koch, L. Heinzerling, B. Odermatt, G. Burg, J. B. Lowe, and T. M. Kundig
Fucosyltransferase VII-Deficient Mice with Defective E-, P-, and L-Selectin Ligands Show Impaired CD4+ and CD8+ T Cell Migration into the Skin, but Normal Extravasation into Visceral Organs
J. Immunol., March 1, 2002; 168(5): 2139 - 2146.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
A. Prevost-Blondel, E. Roth, F. M. Rosenthal, and H. Pircher
Crucial Role of TNF-{alpha} in CD8 T Cell-Mediated Elimination of 3LL-A9 Lewis Lung Carcinoma Cells In Vivo
J. Immunol., April 1, 2000; 164(7): 3645 - 3651.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
G. Geginat, T. Nichterlein, M. Kretschmar, S. Schenk, H. Hof, M. Lalic-Multhaler, W. Goebel, and A. Bubert
Enhancement of the Listeria monocytogenes p60-Specific CD4 and CD8 T Cell Memory by Nonpathogenic Listeria innocua
J. Immunol., April 15, 1999; 162(8): 4781 - 4789.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
This Website Copyright © 1993 by The American Association of Immunologists, Inc. All rights reserved.
All Contents Copyright © 1993 by The American Association of Immunologists, Inc. All rights reserved.